Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
67 "virus"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Methodology of comparative studies on the relative effectiveness of COVID-19 vaccines: a systematic review
Erdenetuya Bolormaa, Jiae Shim, Young-Sook Choi, Donghyok Kwon, Young June Choe, Seung-Ah Choe
Osong Public Health Res Perspect. 2024;15(5):395-408.   Published online October 15, 2024
DOI: https://doi.org/10.24171/j.phrp.2024.0063
  • 895 View
  • 39 Download
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
This study aimed to comprehensively outline the methodological approaches used in published research comparing the vaccine effectiveness (VE) of coronavirus disease 2019 (COVID-19) vaccines.
Methods
A systematic search was conducted on June 13, 2024, to identify comparative studies evaluating the effectiveness of mRNA versus non-mRNA and monovalent versus bivalent COVID-19 vaccines. We screened titles, abstracts, and full texts, collecting data on publication year, country, sample size, study population composition, study design, VE estimates, outcomes, and covariates. Studies that reported relative VE (rVE) were analyzed separately from those that did not.
Results
We identified 25 articles comparing rVE between mRNA and non-mRNA COVID-19 vaccines, as well as between monovalent and bivalent formulations. Among the studies assessing VE by vaccine type, 126 did not provide rVE estimates. Comparative VE studies frequently employed retrospective cohort designs. Among the definitions of rVE used, the most common were hazard ratio and absolute VE, calculated as (1−odds ratio)×100. Studies were most frequently conducted in the United Kingdom and the United States, and the most common outcome was infection. Most targeted the general population and assessed the VE of mRNA vaccines using the AstraZeneca vaccine as a reference. A small proportion, 7.3% (n=11), did not adjust for any variables. Only 3 studies (2.0%) adjusted for all core confounding variables recommended by the World Health Organization.
Conclusion
Few comparative studies of COVID-19 vaccines have incorporated rVE methodologies. Reporting rVE and employing a consistent set of covariates can broaden our understanding of COVID-19 vaccines.
Immunoinformatics approach for design novel multi-epitope prophylactic and therapeutic vaccine based on capsid proteins L1 and L2 and oncoproteins E6 and E7 of human papillomavirus 16 and human papillomavirus 18 against cervical cancer
Nicholas Ryan, Sari Eka Pratiwi, Mardhia Mardhia, Ysrafil Ysrafil, Delima Fajar Liana, Mahyarudin Mahyarudin
Osong Public Health Res Perspect. 2024;15(4):307-328.   Published online July 23, 2024
DOI: https://doi.org/10.24171/j.phrp.2024.0013
  • 1,836 View
  • 87 Download
  • 1 Web of Science
  • 1 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
This study aimed to identify the optimal protein construction for designing a multi-epitope vaccine with both prophylactic and therapeutic effects against cervical cancer, utilizing an immunoinformatics approach. The construction process involved using capsid epitopes L1 and L2, as well as oncoproteins E5, E6, and E7 from human papillomavirus (HPV) types 16 and 18.
Methods
An experimental in silico analysis with an immunoinformatics approach was used to develop 2 multi-epitope vaccine constructs (A and B). Further analysis was then conducted to compare the constructs and select the one with the highest potential against cervical cancer.
Results
This study produced 2 antigenic, non-allergenic, and nontoxic multi-epitope vaccine constructs (A and B), which exhibited the ideal physicochemical properties for a vaccine. Further analysis revealed that construct B effectively induced both cellular and humoral immune responses.
Conclusion
The multi-epitope vaccine construct B for HPV 16 and 18, designed for both prophylactic and therapeutic purposes, met the development criteria for a cervical cancer vaccine. However, these findings need to be validated through in vitro and in vivo experiments.

Citations

Citations to this article as recorded by  
  • Modulation of epithelial homeostasis by HPV using Notch and Wnt
    June See Chong, John Doorbar
    Tumour Virus Research.2024; 18: 200297.     CrossRef
Prevalence and patterns of post-COVID-19 symptoms in recovered patients of Delhi, India: a population-based study
Nidhi Bhatnagar, Mongjam Meghachandra Singh, Hitakshi Sharma, Suruchi Mishra, Gurmeet Singh, Shivani Rao, Amod Borle, Tanu Anand, Naresh Kumar, Binita Goswami, Sarika Singh, Mahima Kapoor, Sumeet Singla, Bembem Khuraijam, Nita Khurana, Urvi Sharma, Suneela Garg
Osong Public Health Res Perspect. 2024;15(3):229-237.   Published online May 17, 2024
DOI: https://doi.org/10.24171/j.phrp.2023.0251
  • 2,381 View
  • 108 Download
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
Post-coronavirus disease 2019 (COVID-19) symptoms were widely reported. However, data on post-COVID-19 conditions following infection with the Omicron variant remained scarce. This prospective study was conducted to understand the prevalence, patterns, and duration of symptoms in patients who had recovered from COVID-19. Methods: A prospective study was conducted across 11 districts of Delhi, India, among individuals who had recovered from COVID-19. Study participants were enrolled, and then returned for post-recovery follow-up at 3 months and 6 months interval. Results: The mean age of study participants was 42.07 years, with a standard deviation of 14.89 years. The majority of the participants (79.7%) reported experiencing post-COVID-19 symptoms. The most common symptoms included joint pain (36.0%), persistent dry cough (35.7%), anxiety (28.4%), and shortness of breath (27.1%). Other symptoms were persistent fatigue (21.6%), persistent headache (20.0%), forgetfulness (19.7%), and limb weakness (18.6%). The longest duration of symptom was observed to be anxiety (138.75±54.14 days), followed by fatigue (137.57±48.33 days), shortness of breath (131.89±60.21 days), and joint pain/swelling (131.59±58.76 days). At the first follow-up visit, 2.2% of participants presented with abnormal electrocardiogram readings, but no abnormalities were noticed during the second follow-up. Additionally, 4.06% of participants exhibited abnormal chest X-ray findings at the first followup, which decreased to 2.16% by the second visit. Conclusion: The most frequently reported post-COVID-19 symptoms were joint pain, dry cough, anxiety and shortness of breath. These clinical symptoms persisted for up to 6 months, with evidence of multi-system involvement. Consequently, findings highlighted the need for long-term follow-up during the post-COVID-19 period.
Genetic diversity and evolutionary patterns of SARS-CoV-2 among the Bhutanese population during the pandemic
Tshering Dorji, Kunzang Dorji, Tandin Wangchuk, Tshering Pelki, Sonam Gyeltshen
Osong Public Health Res Perspect. 2023;14(6):494-507.   Published online December 14, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.0209
  • 2,636 View
  • 76 Download
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
The coronavirus disease 2019 (COVID-19) pandemic, caused by a dynamic virus, has had a profound global impact. Despite declining global COVID-19 cases and mortality rates, the emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants remains a major concern. This study provides a comprehensive analysis of the genomic sequences of SARS-CoV-2 within the Bhutanese population during the pandemic. The primary aim was to elucidate the molecular epidemiology and evolutionary patterns of SARS-CoV-2 in Bhutan, with a particular focus on genetic variations and lineage dynamics. Methods: Whole-genome sequences of SARS-CoV-2 collected from Bhutan between May 2020 and February 2023 (n=135) were retrieved from the Global Initiative on Sharing All Influenza Database. Results: The SARS-CoV-2 variants in Bhutan were predominantly classified within the Nextstrain clade 20A (31.1%), followed by clade 21L (20%) and clade 22D (15.6%). We identified 26 Pangolin lineages with variations in their spatial and temporal distribution. Bayesian time-scaled phylogenetic analysis estimated the time to the most recent common ancestor as February 15, 2020, with a substitution rate of 0.97×10–3 substitutions per site per year. Notably, the spike glycoprotein displayed the highest mutation frequency among major viral proteins, with 116 distinct mutations, including D614G. The Bhutanese isolates also featured mutations such as E484K, K417N, and S477N in the spike protein, which have implications for altered viral properties. Conclusion: This is the first study to describe the genetic diversity of SARS-CoV-2 circulating in Bhutan during the pandemic, and this data can inform public health policies and strategies for preventing future outbreaks in Bhutan.
Vaccine hesitancy in patients with COVID-19 who have back pain
Askeri Türken, Haşim Çapar
Osong Public Health Res Perspect. 2023;14(2):100-109.   Published online March 24, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.0003
  • 3,441 View
  • 84 Download
  • 1 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
Musculoskeletal pain is among the most common symptoms in patients diagnosed with coronavirus disease 2019 (COVID-19), and it has placed a significant burden on health worldwide during the pandemic. This study explored vaccine hesitancy and associated factors in patients with positive COVID-19 polymerase chain reaction test results who were hospitalized and had back pain.
Methods
A cross-sectional study was conducted among 170 hospitalized COVID-19 patients over 18 years of age. Data were analyzed using descriptive statistics with IBM SPSS ver. 25.0.
Results
COVID-19 patients who were married considered COVID-19 vaccinations riskier than unmarried COVID-19 patients. Patients who had not been vaccinated expressed higher levels of distrust towards COVID-19 vaccines than patients who had been vaccinated. Participants had relatively little hesitation toward the Sinovac vaccine. High vaccine confidence was found in all participants regardless of vaccination status. Those who had not received the COVID-19 vaccine reported higher risk perceptions than those who had received at least 1 dose of any COVID-19 vaccine.
Conclusion
Measurements of the hesitancy of vaccinated and non-vaccinated patients or members of society towards vaccines can be an important parameter for health authorities to find solutions.

Citations

Citations to this article as recorded by  
  • COVID-19 VE DAVRANIŞSAL İKTİSAT: KÜRESEL BİR PANDEMİ SIRASINDA İNSAN DAVRANIŞINI ANLAMAK
    İlknur ARSLAN ARAS
    Sağlık ve Sosyal Refah Araştırmaları Dergisi.2024; 6(1): 97.     CrossRef
Review Article
SARS-CoV-2 in brief: from virus to prevention
Hassan Karami, Zeinab Karimi, Negin Karami
Osong Public Health Res Perspect. 2022;13(6):394-406.   Published online November 28, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0155
  • 4,538 View
  • 107 Download
  • 7 Web of Science
  • 9 Crossref
AbstractAbstract PDF
The recent outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ahighly transmissible virus with a likely animal origin, has posed major and unprecedentedchallenges to millions of lives across the affected nations of the world. This outbreak firstoccurred in China, and despite massive regional and global attempts shortly thereafter, itspread to other countries and caused millions of deaths worldwide. This review presents keyinformation about the characteristics of SARS-CoV-2 and its associated disease (namely,coronavirus disease 2019) and briefly discusses the origin of the virus. Herein, we also brieflysummarize the strategies used against viral spread and transmission.

Citations

Citations to this article as recorded by  
  • Cytomegalovirus and pneumocystis jirovecii co-infection pneumonia as an initial presentation of HIV infection
    Sharare Noruzi, Sobhan Mehdipourrabori, Zeynab Yassin
    Journal of Medicine, Surgery, and Public Health.2025; 5: 100174.     CrossRef
  • Mpox virus (MPXV): comprehensive analysis of pandemic risks, pathophysiology, treatments, and mRNA vaccine development
    Sajjad Eslamkhah, Elif Sibel Aslan, Cuneyd Yavas, Nermin Akcalı, Lutfiye Karcıoglu Batur, Asmaa Abuaisha, Erva Esma Yildirim, Mustafa Solak, Kenneth N. White
    Naunyn-Schmiedeberg's Archives of Pharmacology.2025;[Epub]     CrossRef
  • Monkeypox: a re-emergent virus with global health implications – a comprehensive review
    Nourhan G. Naga, Enas A. Nawar, A’laa A. Mobarak, Aya G. Faramawy, Hend M. H. Al-Kordy
    Tropical Diseases, Travel Medicine and Vaccines.2025;[Epub]     CrossRef
  • Polysaccharides and Lectins: A Natural Complementary Approach against the SARS-CoV-2 Pandemic
    Radu Lefter, Prairna Balyan, Ioana-Miruna Balmus, Abdellah Ech-Chahad, Ahmad Ali, Alin Ciobica, Antoneta Dacia Petroaie, Gabriela Halitchi, Bogdan Novac, Catalina Ionescu, Fatima Zahra Kamal
    Microbiology Research.2024; 15(2): 525.     CrossRef
  • Risk of COVID-19 transmission on long-haul flights: During the COVID-19 pandemic
    Jiyun Park, Gye jeong Yeom, Poowin Bunyavejchewin
    PLOS ONE.2024; 19(8): e0309044.     CrossRef
  • Effectiveness of donning and doffing personal protective equipment education using video debriefing among Korean undergraduate nursing students
    GyeJeong Yeom, Jiyun Park
    BMC Nursing.2024;[Epub]     CrossRef
  • A Narrative Review on the Pandemic Zoonotic RNA Virus Infections Occurred During the Last 25 Years
    Gobena Ameni, Aboma Zewude, Begna Tulu, Milky Derara, Berecha Bayissa, Temesgen Mohammed, Berhanu Adenew Degefa, Mohamed Elfatih Hamad, Markos Tibbo, Robert Barigye
    Journal of Epidemiology and Global Health.2024; 14(4): 1397.     CrossRef
  • The next viral pandemic: A call for global preparedness
    Hassan Karami, Mina Soleimani, Negar Nayerain Jazi, Kiana Navi, Rojina Sajadi, Mohammad Mehdi Fazeli, Golara Pagheh, Samane Ostadhadi Dehkordi
    Journal of Medicine, Surgery, and Public Health.2024; 4: 100150.     CrossRef
  • Surveillance of endemic coronaviruses during the COVID‐19 pandemic in Iran, 2021–2022
    Hassan Karami, Kaveh Sadeghi, Sevrin Zadheidar, Fatemeh Saadatmand, Negar Mirsalehi, Nima Hoveidi Ardestani, Shirin Kalantari, Mohammad Farahmand, Jila Yavarian, Talat Mokhtari‐Azad
    Influenza and Other Respiratory Viruses.2023;[Epub]     CrossRef
Original Article
A case-control study of acute hepatitis A in South Korea, 2019
Jung Hee Hyun, Ju Young Yoon, Sang Hyuk Lee
Osong Public Health Res Perspect. 2022;13(5):352-359.   Published online October 12, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0141
  • 4,420 View
  • 139 Download
  • 2 Web of Science
  • 5 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
We aimed to reconfirm the source of hepatitis A virus (HAV) infection through epidemiological and genotype investigations of individual cases in a 2019 outbreak in South Korea. Methods: We investigated food intake histories, associations with hepatitis A, and genotypes of HAV in 31 patients with hepatitis aged 20 to 49 years registered in the integrated disease and health management system during December 1–7, 2019 (case group) and in 35 sex- and agematched people without a history of HAV vaccination or infection among patients’ families and colleagues (control group). Results: The consumption of salted clams was a significant factor (odds ratio, 4.33; 95% confidence interval, 1.32–14.18) in the risk factor analysis of food intake history. HAV genotypes were analyzed in 24 of 31 patients. Type IA and type IIIA were found in 23 and 1 cases, respectively. Conclusion: Salted clams are considered to have been the source of HAV infection at 49 weeks of the HAV outbreak in 2019; this result was consistent with that of a previous epidemiological investigation conducted by the Korea Disease Control and Prevention Agency in September 2019. Therefore, monitoring of the production and distribution of salted clams needs to be continued.

Citations

Citations to this article as recorded by  
  • Monitoring viruses and beta-lactam resistance genes through wastewater surveillance during a COVID-19 surge in Suwon, South Korea
    Rajendra Singh, Jaewon Ryu, Sung Soo Park, Sungpyo Kim, Keugtae Kim
    Science of The Total Environment.2024; 922: 171223.     CrossRef
  • Prevalence of Enteric Viruses in Raw Seafood Collected from the Retail Shops in Tehran, Iran, 2022–2023
    Golshid Javdani Shahedin, Maryam Yazdanizad, Seyed Davood Mousavi Nasab, Delaram Doroud, Rahman Shokri, Ramin Mazaheri Nezhad Fard
    Iranian Journal of Medical Microbiology.2024; 18(3): 190.     CrossRef
  • Prevalence of foodborne viruses and influenza A virus from poultry processing plants to retailed chickens
    Daseul Yeo, Mengxiao Song, Md. Iqbal Hossain, Soontag Jung, Zhaoqi Wang, Dong Joo Seo, Min Suk Rhee, Changsun Choi
    Frontiers in Sustainable Food Systems.2023;[Epub]     CrossRef
  • A Study on the Detection Rate of Hepatitis A from Gastroenteritis Patients and the Genotype Analysis of Hepatitis A Virus in Busan
    Sun Hee Park, Chanhee Kim, Summi Lee, Jihye Jeong, Junghye Choi, Seung Ju Lee
    Journal of Bacteriology and Virology.2023; 53(2): 74.     CrossRef
  • A Study on the Detection Rate of Hepatitis A from Gastroenteritis Patients and the Genotype Analysis of Hepatitis A Virus in Busan
    Sun Hee Park, Chanhee Kim, Summi Lee, Jihye Jeong, Junghye Choi, Seung Ju Lee
    Journal of Bacteriology and Virology.2023; 53(2): 74.     CrossRef
Review Article
Zika virus as an emerging arbovirus of international public health concern
Samira Vaziri, Siavash Hamzeh Pour, Fateme Akrami-Mohajeri
Osong Public Health Res Perspect. 2022;13(5):341-351.   Published online October 12, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0101
  • 4,178 View
  • 155 Download
  • 5 Web of Science
  • 6 Crossref
AbstractAbstract PDF
Zika virus (ZIKV) was identified in 1947 in a rhesus monkey during an investigation of the yellow fever virus in the Zika Forest of Uganda; it was also isolated later from humans in Nigeria. The main distribution areas of ZIKV were the African mainland and South-East Asia in the 1980s, Micronesia in 2007, and more recently the Americas in 2014. ZIKV belongs to the Flaviviridae family and Flavivirus genus. ZIKV infection, which is transmitted by Aedes mosquitoes, is an emerging arbovirus disease. The clinical symptoms of ZIKV infection are fever, headache, rashes, arthralgia, and conjunctivitis, which clinically resemble dengue fever syndrome. Sometimes, ZIKV infection has been associated with Guillain-Barré syndrome and microcephaly. At the end of 2015, following an increase in cases of ZIKV infection associated with Guillain-Barré syndrome and microcephaly in newborns in Brazil, the World Health Organization declared a global emergency. Therefore, considering the global distribution and pathogenic nature of this virus, the current study aimed at reviewing the virologic features, transmission patterns, clinical manifestations, diagnosis, treatment, and prevention of ZIKV infection.

Citations

Citations to this article as recorded by  
  • A Review on The Pathogenesis of Cardiovascular Disease of Flaviviridea Viruses Infection
    Tie-Hua Yang, Wen-Cong Gao, Xin Ma, Qian Liu, Pan-Pan Pang, Yong-Tang Zheng, Yinnong Jia, Chang-Bo Zheng
    Viruses.2024; 16(3): 365.     CrossRef
  • The race against time: Zika virus on the horizon in Pakistan
    Moiz Ahmed Khan, Summaiya Zafar
    Tropical Doctor.2024; 54(3): 231.     CrossRef
  • Zika’s resurgence in Thailand: a 300% surge demands urgent action
    Shriyansh Srivastava, Sachin Kumar, Nandani Jayaswal, Rachana Mehta, Prakasini Satapathy, Aroop Mohanty, Ranjit Sah
    International Journal of Surgery Open.2024; 62(2): 180.     CrossRef
  • Zika virus tropism and pathogenesis: understanding clinical impacts and transmission dynamics
    Saeed Tajik, Ali Vasheghani Farahani, Omid Salahi Ardekani, Saba Seyedi, Zahra Tayebi, Mostafa Kami, Faezeh Aghaei, Tahmine Mohammad Hosseini, Mohammad Mahdi Khosravi Nia, Roben Soheili, Arash Letafati
    Virology Journal.2024;[Epub]     CrossRef
  • Predição de casos de arboviroses no Recife utilizando computação de reservatório
    Ana Clara Gomes Da Silva, Cláudia Priscila Nunes Silva, Clarisse Lins De Lima, Danilo Wanderley Lapa, Felipe Estevão Da Silva, Mariana Marinho da Silva Andrade, Arianne Sarmento Torcate, Cecília Cordeiro Da Silva, Giselle Machado Magalhães Moreno, Welling
    Journal of Health Informatics.2024;[Epub]     CrossRef
  • Zika virus disease: an alarming situation resurfacing on the radar – a short communication
    Sanobar Shariff, Burhan Kantawala, Nakyanzi Hamiidah, Tularam Yadav, Abubakar Nazir, Olivier Uwishema
    Annals of Medicine & Surgery.2023; 85(10): 5294.     CrossRef
Brief Report
Isolation and identification of monkeypox virus MPXV-ROK-P1-2022 from the first case in the Republic of Korea
Jin-Won Kim, Minji Lee, Hwachul Shin, Chi-Hwan Choi, Myung-Min Choi, Jee Woong Kim, Hwajung Yi, Cheon-Kwon Yoo, Gi-Eun Rhie
Osong Public Health Res Perspect. 2022;13(4):308-311.   Published online August 31, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0232
  • 9,010 View
  • 188 Download
  • 10 Web of Science
  • 10 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
Monkeypox outbreaks in nonendemic countries have been reported since early May 2022. The first case of monkeypox in the Republic of Korea was confirmed in a patient who traveled to Europe in June 2022, and an attempt was made to isolate and identify the monkeypox virus (MPXV) from the patient’s specimens.
Methods
Clinical specimens from the patient were inoculated in Vero E6 cells. The isolated virus was identified as MPXV by the observation of cytopathic effects on Vero E6 cells, transmission electron microscopy, conventional polymerase chain reaction (PCR), and sequencing of PCR products.
Results
Cytopathic effects were observed in Vero E6 cells that were inoculated with skin lesion swab eluates. After multiple passages from the primary culture, orthopoxvirus morphology was observed using transmission electron microscopy. In addition, both MPXV-specific (F3L and ATI) and orthopoxvirus-specific genes (A39R, B2R, and HA) were confirmed by conventional PCR and Sanger sequencing.
Conclusion
These results indicate the successful isolation and identification of MPXV from the first patient in the Republic of Korea. The isolated virus was named MPXV-ROK-P1-2022.

Citations

Citations to this article as recorded by  
  • MPXV: Update on Morphological and Morphogenesis Aspects Through Transmission and Scanning Electron Microscopies and 3D Reconstruction
    Debora Ferreira Barreto‐Vieira, Milene Dias Miranda, Marcos Alexandre Nunes da Silva, Andressa Santos de Almeida, Ana Luisa Teixeira de Almeida, Derick Mendes Bandeira, Vivian Neuza S. Ferreira, Alice Santos Rosa, Wendell Girard‐Dias, Bráulio Soares Archa
    Journal of Medical Virology.2025;[Epub]     CrossRef
  • Ultrasensitive one-pot detection of monkeypox virus with RPA and CRISPR in a sucrose-aided multiphase aqueous system
    Yue Wang, Yixin Tang, Yukang Chen, Guangxi Yu, Xue Zhang, Lihong Yang, Chenjie Zhao, Pei Wang, Song Gao, Frederick S. B. Kibenge, Ruijie Deng, Wei Chen, Shuang Yang
    Microbiology Spectrum.2024;[Epub]     CrossRef
  • Molecular Methods for Diagnosis of Monkeypox: A Mini-review
    Rodrigo Michelini de Oliveira Thomasi, Thais da Silva Correa, Dalise Silva do Carmo, Déborah Fernandes Rodrigues, Luiz Vinicius da Silva Correa, Sandra Rodrigues Xavier, Líria Souza Silva, Jonatas Oliveira da Silva, Michelli dos Santos, Alessandra da Silv
    Current Molecular Medicine.2024; 24(10): 1208.     CrossRef
  • Epidemiological, Clinical, and Virological Investigation of the First Four Cases of Monkeypox in Cartagena during the 2022 Outbreak
    Steev Loyola, Mashiel Fernández-Ruiz, Doris Gómez-Camargo
    Pathogens.2023; 12(2): 159.     CrossRef
  • 원숭이두창바이러스의 분리 배양과 전장유전체 정보 분석
    민지 이, 진원 김, 치환 최, 화철 신, 명민 최, 상은 이, 화중 이, 윤석 정
    Public Health Weekly Report.2023; 16(15): 464.     CrossRef
  • Overview of Diagnostic Methods, Disease Prevalence and Transmission of Mpox (Formerly Monkeypox) in Humans and Animal Reservoirs
    Ravendra P. Chauhan, Ronen Fogel, Janice Limson
    Microorganisms.2023; 11(5): 1186.     CrossRef
  • How to cope with suspected mpox patients in the outpatient clinic
    Nam Joong Kim, Sun Huh
    Journal of the Korean Medical Association.2023; 66(5): 325.     CrossRef
  • An Updated Review on Monkeypox Viral Disease: Emphasis on Genomic Diversity
    Ali Rabaan, Nada Alasiri, Mohammed Aljeldah, Abeer Alshukairiis, Zainab AlMusa, Wadha Alfouzan, Abdulmonem Abuzaid, Aref Alamri, Hani Al-Afghani, Nadira Al-baghli, Nawal Alqahtani, Nadia Al-baghli, Mashahed Almoutawa, Maha Mahmoud Alawi, Mohammed Alabdull
    Biomedicines.2023; 11(7): 1832.     CrossRef
  • Monkeypox (Mpox) virus isolation and ultrastructural characterisation from a Brazilian human sample case
    Milene Dias Miranda, Gabriela Cardoso Caldas, Vivian Neuza Ferreira, Ortrud Monika Barth, Aline de Paula Dias da Silva, Mayara Secco Torres Silva, Beatriz Grinsztejn, Valdiléa Gonçalves Veloso, Thiago Moreno Souza, Edson Elias da Silva, Debora Ferreira Ba
    Memórias do Instituto Oswaldo Cruz.2023;[Epub]     CrossRef
  • Isolation and Characterization of Monkeypox Virus from the First Case of Monkeypox — Chongqing Municipality, China, 2022
    Baoying Huang, Hua Zhao, Jingdong Song, Li Zhao, Yao Deng, Wen Wang, Roujian Lu, Wenling Wang, Jiao Ren, Fei Ye, Houwen Tian, Guizhen Wu, Hua Ling, Wenjie Tan
    China CDC Weekly.2022; 4(46): 1019.     CrossRef
Short Communication
COVID-19 outbreak and risk factors for infection in a taekwondo gym in the Republic of Korea
Seung Hwan Shin, Eonjoo Park, Sookhyun Kim, Minji Jang, Subin Park, Dong-Hwi Kim, Tae Jong Son, Ji-Hyuk Park
Osong Public Health Res Perspect. 2022;13(2):162-170.   Published online March 31, 2022
DOI: https://doi.org/10.24171/j.phrp.2021.0295
  • 5,779 View
  • 123 Download
  • 10 Web of Science
  • 9 Crossref
AbstractAbstract PDF
Objectives
Relatively few studies have assessed risk factors for coronavirus disease 2019 (COVID-19) in public facilities used by children and adolescents. This study presents an analysis of a COVID-19 outbreak that occurred in a taekwondo gym in Korea, predominantly among children and adolescents, with the aim of providing insights on managing COVID-19 outbreaks in similar facilities. Methods: All 108 taekwondo gym students and staff received COVID-19 tests. A survey and closed-circuit television analyses were used to identify risk factors. A univariate analysis was conducted, followed by multivariate logistic regression analysis with backward elimination for variables with a significance level <0.10 in the univariate analysis. Results: COVID-19 was confirmed in 30 of 108 subjects at the taekwondo gym (attack rate, 27.8%). The outbreak started in an adult class student. This student transmitted the virus to the staff, who consequently transmitted the virus to adolescent students. In the univariate analysis, the relative risk for younger age (≤9 years) was 2.14 (95% confidence interval [CI], 1.01–4.54; p=0.054), and that for food consumption inside the gym was 2.12 (95% CI, 1.04–4.30; p=0.048). In the multivariate logistic regression analysis, the odds ratio for younger age was 2.96 (95% CI, 1.07–8.20; p=0.036), and that for food consumption inside the gym was 3.00 (95% CI, 1.10–8.17; p=0.032). Conclusion: Food consumption inside the facility and young age were significant risk factors for COVID-19 transmission in this taekwondo gym. Food consumption should be prohibited in sports facilities, and infection prevention education for young students is also required.

Citations

Citations to this article as recorded by  
  • The First Outbreak of Novel Coronavirus Disease 2019 (COVID-19) at an Outdoor Camping Site in South Korea, 2020
    Na-Young Kim, Seonhee Ahn, GwangJin Kim, Donghyok Kwon, Young-Joon Park, Sang-Eun Lee
    Journal of Epidemiology.2024; 34(4): 203.     CrossRef
  • Risk evaluation of venue types and human behaviors of COVID-19 outbreaks in public indoor environments: A systematic review and meta-analysis
    Weiwei Huang, Caroline X. Gao, Danting Luo, Yong Wang, Xiaohong Zheng, Cong Liu, Ying Wang, Yuguo Li, Hua Qian
    Environmental Pollution.2024; 341: 122970.     CrossRef
  • Investigating Factors Contributing to the Occurrence of COVID-19 Outbreaks in Athletes in a Scoping Review
    Shuichi KASAMA, Haruyo SAKAKI, Eiko ENDO
    Taiikugaku kenkyu (Japan Journal of Physical Educa.2024; 69: 151.     CrossRef
  • The Risk of SARS-CoV-2 Transmission in Community Indoor Settings: A Systematic Review and Meta-analysis
    Mark Rohit Francis, Saheed Gidado, J Pekka Nuorti
    The Journal of Infectious Diseases.2024;[Epub]     CrossRef
  • Identifying risk factors for COVID-19 cluster infections in schools in the Republic of Korea: a case-control study
    Jihyun Choi, Seongju Choi, Baigu Lee, Young-Joon Park, Sang Eun Lee
    Osong Public Health and Research Perspectives.2024; 15(4): 375.     CrossRef
  • Causes of COVID-19 Outbreaks During Sports and Exercise: A Systematic Review
    Masaki Machida, Koichi Dai, Itaru Nakamura, Shigeru Inoue
    Sports Medicine.2024;[Epub]     CrossRef
  • SARS-CoV-2 transmission modes: Why and how contamination occurs around shared meals and drinks?
    Aure Saulnier, Jean-Michel Wendling, Benoit Hermant, Didier Lepelletier
    Food Microbiology.2023; 114: 104297.     CrossRef
  • Risk factors for COVID-19 outbreaks in livestock slaughtering and processing facilities in Republic of Korea
    Seongju Choi, Tae Jong Son, Yeon-Kyung Lee
    Osong Public Health and Research Perspectives.2023; 14(3): 207.     CrossRef
  • Protective facemask-induced facial thermal stress and breathing burden during exercise in gyms
    Qilong Zhong, Jiyun Song, Dachuan Shi, Chung-Hin Dung
    Building and Environment.2023; 244: 110840.     CrossRef
Review Article
Worldwide prevalence of fungal coinfections among COVID-19 patients: a comprehensive systematic review and meta-analysis
Saber Soltani, Milad Zandi, Samireh Faramarzi, Ramin Shahbahrami, Mohebat Vali, Sara Akhavan Rezayat, Reza Pakzad, Pooneh Malekifar, Iraj Pakzad, Neda Jahandoost, Jalal Moludi
Osong Public Health Res Perspect. 2022;13(1):15-23.   Published online February 8, 2022
DOI: https://doi.org/10.24171/j.phrp.2021.0293
  • 8,774 View
  • 132 Download
  • 10 Web of Science
AbstractAbstract PDFSupplementary Material
Microbial coinfections can increase the morbidity and mortality rates of viral respiratory diseases. Therefore, this study aimed to determine the pooled prevalence of fungal coinfections in coronavirus disease 2019 (COVID-19) patients. Web of Science, Medline, Scopus, and Embase were searched without language restrictions to identify the related research on COVID-19 patients with fungal coinfections from December 1, 2019, to December 30, 2020. A random-effects model was used for analysis. The sample size included 2,246 patients from 8 studies. The pooled prevalence of fungal coinfections was 12.60%. The frequency of fungal subtype coinfections was 3.71% for Aspergillus, 2.39% for Candida, and 0.39% for other. The World Health Organization’s Regional Office for Europe and Regional Office for Southeast Asia had the highest (23.28%) and lowest (4.53%) estimated prevalence of fungal coinfection, respectively. Our findings showed a high prevalence of fungal coinfections in COVID-19 cases, which is a likely contributor to mortality in COVID-19 patients. Early identification of fungal pathogens in the laboratory for COVID-19 patients can lead to timely treatment and prevention of further damage by this hidden infection.
Original Article
Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea
Eun Ju Oh, Young Sam Yuk, Jae Kyung Kim
Osong Public Health Res Perspect. 2021;12(6):385-389.   Published online December 1, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.0146
  • 7,942 View
  • 107 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDF
Objectives
Herpes simplex virus (HSV) infections have been reported in 60% to 95% of the adult population worldwide, making them one of the most common infectious conditions globally. HSV-1 and HSV-2 cause severe disease in immunocompromised patients. Therefore, the aim of this study was to provide information that could be used to reduce the incidence of genital herpes caused by HSV-1 and HSV-2.
Methods
From September 2018 to December 2020, 59,381 specimens were collected from outpatients across primary and secondary hospitals in Korea who requested U2Bio (Seoul, Korea) to conduct molecular biological testing of their samples for sexually transmitted infections. In this study, the positivity rates of HSV-1 and HSV-2 were analyzed according to age, sex, and specimen type.
Results
In the age-specific analysis of HSV-1, the highest positivity rate (0.58%) was observed in patients under 19 years of age, whereas the lowest positivity rate (0.08%) was observed in patients aged over 70 years. In the age-specific analysis of HSV-2, the highest positivity rate (2.53%) was likewise observed in patients under 19 years of age.
Conclusion
Our study identified differences in the infection rates of HSV-1 and HSV-2 depending on patients’ sex and age. These differences will be useful for improving disease prevention and control measures for HSV-1 and HSV-2.

Citations

Citations to this article as recorded by  
  • Rapid diagnosis of herpes simplex virus 1 and 2 bloodstream infections utilizing a sample-to-answer platform
    Wei Zhen, Farah Sheikh, Dwayne A. Breining, Gregory J. Berry, Melissa B. Miller
    Journal of Clinical Microbiology.2024;[Epub]     CrossRef
  • Analysis of HSV1/2 Infection Reveals an Association between HSV-2 Reactivation and Pregnancy
    Sara Dovrat, Adar Shabat, Anat Yahav-Dovrat, Zvia Soufiev, Ella Mendelson, Ela Kashi-Zagdoun, Galia Rahav
    Viruses.2024; 16(9): 1370.     CrossRef
Review Articles
The role of lipids in the pathophysiology of coronavirus infections
Milad Zandi, Parastoo Hosseini, Saber Soltani, Azadeh Rasooli, Mona Moghadami, Sepideh Nasimzadeh, Farzane Behnezhad
Osong Public Health Res Perspect. 2021;12(5):278-285.   Published online October 15, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.0153
  • 7,181 View
  • 179 Download
  • 2 Web of Science
  • 3 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Coronaviruses, which have been known to cause diseases in animals since the 1930s, utilize cellular components during their replication cycle. Lipids play important roles in viral infection, as coronaviruses target cellular lipids and lipid metabolism to modify their host cells to become an optimal environment for viral replication. Therefore, lipids can be considered as potential targets for the development of antiviral agents. This review provides an overview of the roles of cellular lipids in different stages of the life cycle of coronaviruses.

Citations

Citations to this article as recorded by  
  • PEDV inhibits HNRNPA3 expression by miR-218-5p to enhance cellular lipid accumulation and promote viral replication
    Xiaojie Shi, Qi Zhang, Naling Yang, Quanqiong Wang, Yanxia Zhang, Xingang Xu, Xiang-Jin Meng, Ying Fang
    mBio.2024;[Epub]     CrossRef
  • Understanding the Molecular Actions of Spike Glycoprotein in SARS-CoV-2 and Issues of a Novel Therapeutic Strategy for the COVID-19 Vaccine
    Yasunari Matsuzaka, Ryu Yashiro
    BioMedInformatics.2024; 4(2): 1531.     CrossRef
  • Orsay Virus Infection of Caenorhabditis elegans Is Modulated by Zinc and Dependent on Lipids
    Luis Alberto Casorla-Perez, Ranya Guennoun, Ciro Cubillas, Bo Peng, Kerry Kornfeld, David Wang, Rebecca Ellis Dutch
    Journal of Virology.2022;[Epub]     CrossRef
Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children
Milad Zandi, Saber Soltani, Mona Fani, Samaneh Abbasi, Saeedeh Ebrahimi, Ali Ramezani
Osong Public Health Res Perspect. 2021;12(5):286-292.   Published online October 1, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.0140
  • 8,365 View
  • 173 Download
  • 13 Web of Science
  • 10 Crossref
AbstractAbstract PDF
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has infected many people around the world. Children are considered an important target group for SARS-CoV-2, as well as other viral infections such as respiratory syncytial virus infection. Both SARS-CoV-2 and respiratory syncytial virus can affect the respiratory tract. Coinfection of SARS-CoV-2 and respiratory syncytial virus can pose significant challenges in terms of diagnosis and treatment in children. This review compares the symptoms, diagnostic methods, and treatment of COVID-19 and respiratory syncytial virus infection in children.

Citations

Citations to this article as recorded by  
  • Evaluating an extraction-free sample preparation method for multiplex detection of SARS-Cov-2, influenza A/B, and RSV with implementation on a microfluidic chip
    Fatemeh Ahmadi, Fatemeh Zahra Zanganeh, Iman Amani Tehrani, Saeed Shoaee, Hamzeh Choobin, Ali Bozorg, Mojtaba Taghipoor
    Diagnostic Microbiology and Infectious Disease.2024; 109(3): 116325.     CrossRef
  • Design of multivalent-epitope vaccine models directed toward the world’s population against HIV-Gag polyprotein: Reverse vaccinology and immunoinformatics
    Ava Hashempour, Nastaran Khodadad, Peyman Bemani, Younes Ghasemi, Shokufeh Akbarinia, Reza Bordbari, Amir Hossein Tabatabaei, Shahab Falahi, Anoop Kumar
    PLOS ONE.2024; 19(9): e0306559.     CrossRef
  • Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019–2020
    Thomas Williams, Sandra Jackson, Ian Barr, Shabana Bi, Jinal Bhiman, Joanna Ellis, Anne von Gottberg, Stephen Lindstrom, Teresa Peret, Sanjiv Rughooputh, Mariana Viegas, Siddhivinayak Hirve, Maria Zambon, Wenqing Zhang
    Influenza and Other Respiratory Viruses.2023;[Epub]     CrossRef
  • The Impact of Coronavirus Disease 2019 on Viral, Bacterial, and Fungal Respiratory Infections
    Ashley Losier, Gayatri Gupta, Mario Caldararo, Charles S. Dela Cruz
    Clinics in Chest Medicine.2023; 44(2): 407.     CrossRef
  • Viral Coinfection of Children Hospitalized with Severe Acute Respiratory Infections during COVID-19 Pandemic
    Célia Regina Malveste Ito, André Luís Elias Moreira, Paulo Alex Neves da Silva, Mônica de Oliveira Santos, Adailton Pereira dos Santos, Geovana Sôffa Rézio, Pollyanna Neta de Brito, Alana Parreira Costa Rezende, Jakeline Godinho Fonseca, Fernanda Aparecid
    Biomedicines.2023; 11(5): 1402.     CrossRef
  • Clinical Relevance of RSV and SARS-CoV-2 Coinfections in Infants and Young Children
    Rosa Rodriguez-Fernandez, Felipe González-Martínez, Jimena Perez-Moreno, María Isabel González-Sánchez, Blanca Toledo del Castillo, Irene Mingueza de la Paz, Laura Diaz Pozo, Asuncion Mejias, Octavio Ramilo
    Pediatric Infectious Disease Journal.2023; 42(12): e473.     CrossRef
  • Targeting Host Calcium Channels and Viroporins: A Promising Strategy for SARS-CoV-2 Therapy
    Mona Fani, Maryam Moossavi, Hasan Bakhshi, Abozar Nasiri Jahrodi, Mohammad Reza Khazdair, Amir Hossein Zardast, Shokouh Ghafari
    Future Virology.2023; 18(12): 797.     CrossRef
  • Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions
    Elly Binns, Jane Tuckerman, Paul V Licciardi, Danielle Wurzel
    Journal of Paediatrics and Child Health.2022; 58(10): 1741.     CrossRef
  • Impact of genetic polymorphisms related to innate immune response on respiratory syncytial virus infection in children
    Laura Elena Córdova-Dávalos, Alicia Hernández-Mercado, Claudia Berenice Barrón-García, Augusto Rojas-Martínez, Mariela Jiménez, Eva Salinas, Daniel Cervantes-García
    Virus Genes.2022; 58(6): 501.     CrossRef
  • Clinical and epidemiological characteristics of SARS-CoV-2 virus in ambulatory children under 2 years old
    Carolina A. Perez, Ivana Ormazabal, Javier Pérez-Valenzuela, Andrea Araya, Rafael A. Medina, Cecilia Perret
    Frontiers in Pediatrics.2022;[Epub]     CrossRef
Brief Report
The laboratory test procedure to confirm rotavirus vaccine infection in severe complex immunodeficiency patients
Su-Jin Chae, Seung-Rye Cho, Wooyoung Choi, Myung-Guk Han, Deog-Yong Lee
Osong Public Health Res Perspect. 2021;12(4):269-273.   Published online August 13, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.0079
  • 5,856 View
  • 103 Download
  • 1 Crossref
AbstractAbstract PDF
The rotavirus vaccine is a live vaccine, and there is a possibility of infection by the virus strain used in the vaccine. We investigated the process of determining whether an infection was caused by the vaccine strain in a severe complex immunodeficiency (SCID) patient with rotavirus infection. The patient was vaccinated with RotaTeq prior to being diagnosed with SCID. The testing process was conducted in the following order: confirming rotavirus infection, determining its genotype, and confirming the vaccine strain. Rotavirus infection was confirmed through enzyme immunoassay and VP6 gene detection. G1 and P[8] were identified by multiplex polymerase chain reaction for the genotype, and G3 was further identified using a single primer. By detecting the fingerprint gene (WC3) of RotaTeq, it was confirmed that the detected virus was the vaccine strain. Genotypes G1 and P[8] were identified, and the infection was suspected of having been caused by rotavirus G1P[8]. G1P[8] is the most commonly detected genotype worldwide and is not included in the recombinant strains used in vaccines. Therefore, the infection was confirmed to have been caused by the vaccine strain by analyzing the genetic relationship between VP4 and VP7. Rotavirus infection by the vaccine strain can be identified through genotyping and fingerprint gene detection. However, genetic linkage analysis will also help to identify vaccine strains.

Citations

Citations to this article as recorded by  
  • Enhanced numerical techniques for solving generalized rotavirus mathematical model via iterative method and ρ-Laplace transform
    Rishi Kumar Pandey, Kottakkaran Sooppy Nisar
    Partial Differential Equations in Applied Mathemat.2024; 12: 100963.     CrossRef

PHRP : Osong Public Health and Research Perspectives
TOP